Expression of cancer stem markers could be influenced by silencing of p16 gene in HeLa cervical carcinoma cells

Effect of the tumor suppression gene p16 on the biological characteristics of HeLa cervical carcinoma cells was explored. The expression of p16 protein was increased in HeLa tumor sphere cells, and no significant difference in tumor spheres from the first to the fourth passages. Compared with those of parental HeLa cells, the proportion of CD44+/CD24- and ABCG2+ cells increased significantly in tumor spheres. However after the cells were silenced by the p16-sh289 vector, expression of P16 protein and the cell number of CD44+/CD24- and ABCG2+ decreased. Moreover, HeLa cells with p16 gene silencing showed decreased abilities of sphere formation and matrigel invasion. More HeLa cells with p16 gene silence were needed for tumor formation in nude mice. Tumor size and weight in mouse model established with p16 gene silenced HeLa cells were less than those with HeLa parental cell model. The present results indicate that silencing of the p16 gene inhibits expression of cancer stem cell markers and tumorigenic ability of HeLa cells.

p16; Gene silencing; HeLa cell; Cancer stem cell; shRNA; CD44; CD24; ABCG2.

[1] Singh M., Mockler D., Akalin A., Burke S., Shroyer A., Shroyer K.R.: “Immunocytochemical colocalization of P16(INK4a) and Ki- 67 predicts CIN2/3 and AIS/adenocarcinoma”. Cancer Cytopathol., 2012, 120, 26.

[2] Huang L.W., Lee C.C.: “P16INK4A overexpression predicts lymph node metastasis in cervical carcinomas”. J. Clin. Pathol., 2012, 65, 117.

[3] Uleberg K.E., Munk A.C., Brede C., Gudlaugsson E., van Diermen B., Skaland I., et al.: “Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies”. Proteome Sci., 2011, 9, 36.

[4] Kostopoulou E., Samara M., Kollia P., Zacharouli K., Mademtzis I., Daponte A., et al.: “Different patterns of p16 immunoreactivity in cervical biopsies: correlation to lesion grade and HPV detection, with a review of the literature”. Eur. J. Gynaecol. Oncol., 2011, 32, 54.

[5] Yoshida T., Sano T., Kanuma T., Inoue H., Itoh T., Yazaki C., et al.: “Usefulness of CINtec® PLUS p16/Ki-67 double-staining in cytological screening of cervical cancer”. Acta Cytol., 2011, 55, 413.

[6] Vijayalakshmi N., Selvaluxmi G., Majhi U., Rajkumar T.: “Alterations found in pl6/Rb/cyclin D1 pathway in the dysplastic and malignant cervical epithelium”. Oncol. Res., 2007, 16, 527.

[7] Bischof O., Nacerddine K., Dejean A.: “Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways”. Mol. Cell. Biol., 2005, 25, 1013.

[8] Bahnassy A.A., Zekri A.R., Alam El-Din H.M., Aboubakr A.A., Kamel K., El-Sabah M.T., et al.: “The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma” J. Egypt. Natl. Canc. Inst., 2006, 18, 292.

[9] Kumazawa S., Kajiyama H., Umezu T., Mizuno M., Suzuki S., Yamamoto E., et al.: “Possible association between stem-like hallmark and radioresistance in human cervical carcinoma cells”. J. Obstet. Gynaecol. Res., 2014, 40, 1389.

[10] Shen L., Huang X., Xie X., Su J., Yuan J., Chen X.: “High expression of SOX2 and OCT4 indicates radiation resistance and an independent negative prognosis in cervical squamous cell carcinoma. J. Histochem. Cytochem., 2014, 62, 499.

[11] Liu X.F., Yang W.T., Xu R., Liu J.T., Zheng P.S.: “Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells”. PLoS One, 2014, 9, e87092.

[12] Reya T., Morrison S.J., Clarke M.F., Weissman I.L.: “Stem cells, cancer, and cancer stem cells”. Nature, 2001, 414, 105.

[13] Gu W., Yeo E., McMillan N., Yu C.: “Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability”. Cancer Gene Ther., 2011, 18, 897.

[14] Bortolomai I., Canevari S., Facetti I., De Cecco L., Castellano G., Zacchetti A., et al.: “Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension”. Cell Cycle, 2010, 9, 1194.

[15] Feng D., Peng C., Li C., Zhou Y., Li M., Ling B., et al.: “Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri”. Oncol. Rep., 2009, 22, 1129.

[16] Yin T.,Wei H., Gou S., Shi P.,Yang Z., Zhao G., et al.: “Cancer stemlike cells enriched in panc-1 spheres possess increased migration ability and resistance to gemcitabine”. Int. J. Mol. Sci., 2011, 12, 1595.

[17] Jordan C.T.: “Cancer stem cell biology: from leukemia to solid tumors”. Curr. Opin. Cell. Biol., 2004, 16, 708.

[18] Huntly B.J., Gilliland D.G.: “Leukaemia stem cells and the evolution of cancer-stem-cell research”. Nat. Rev. Cancer, 2005, 5, 311.

[19] Zhang C.Y., Bao W., Wang L.H.: “Down regulation of p16(ink4a) inhibits cell proliferation and induces G1 cell cycle arrest in cervical cancer cells”. Int. J. Mol. Med., 2014, 33, 1577.